药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Flurandrenolide
Isoprenaline
The risk or severity of Tachycardia can be increased when Isoprenaline is combined with Chlorprothixene.
Flurandrenolide
Oxymetazoline
The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Chlorprothixene.
Flurandrenolide
Bitolterol
The risk or severity of Tachycardia can be increased when Bitolterol is combined with Chlorprothixene.
Flurandrenolide
Ritodrine
The risk or severity of Tachycardia can be increased when Ritodrine is combined with Chlorprothixene.
Flurandrenolide
Gilteritinib
The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Gilteritinib.
Flurandrenolide
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Chlorprothixene.
Flurandrenolide
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Chlorprothixene.
Flurandrenolide
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Chlorprothixene.
Flurandrenolide
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Chlorprothixene.
Flurandrenolide
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Chlorprothixene.
Flurandrenolide
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Chlorprothixene.
Flurandrenolide
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Chlorprothixene.
Flurandrenolide
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Chlorprothixene.
Flurandrenolide
Cannabidiol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorprothixene.
Flurandrenolide
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Chlorprothixene.
Flurandrenolide
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with Chlorprothixene.
Flurandrenolide
SLV319
The risk or severity of adverse effects can be increased when SLV319 is combined with Chlorprothixene.
Flurandrenolide
Naxitamab
Chlorprothixene may increase the neurotoxic activities of Naxitamab.
Flurandrenolide
Viomycin
Chlorprothixene may increase the neurotoxic activities of Viomycin.
Flurandrenolide
Neomycin
Neomycin may increase the neurotoxic activities of Chlorprothixene.